Latest News of AKBA
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Just Reported And Analysts Have Been Lifting Their Price Targets
Akebia Therapeutics saw an 11% drop in stock after reporting Q4 results, with mixed analyst opinions. Revenue forecasts show a 3% decline in 2024, with losses expected to increase....
Must the show go on? Theatre's plucky motto may be out of step with our times | Arifa Akbar
This summer, stage performances faced delays, cancellations, and postponements, sparking discussions about a possible cultural shift. The industry is adapting post-Covid, prioritizing health and safet...
Further weakness as Akebia Therapeutics (NASDAQ:AKBA) drops 16% this week, taking five-year losses to 80%
Long-term investing is advisable, but not every stock should be held forever to avoid major losses. Akebia Therapeutics (NASDAQ: AKBA) shareholders suffered an 80% drop in 5 years and 57% in the last ...
-
Palestinians mark 1948 Nakba in the shadow of war in Gaza
By Reuters | 5 months agoBy Mohammad Salem and James MackenzieGAZA/JERUSALEM (Reuters) - Palestinians commemorated the 1948 "Nakba" or catastrophe, on Wednesday, marking the time when hundreds of thousands were dispossess...
-
Palestinians in Israel demand refugee return on 'Nakba' anniversary
By Reuters | 5 months agoBy Henriette ChacarNEAR HAIFA, Israel (Reuters) - Thousands of flag-waving Palestinians marched in northern Israel on Tuesday to commemorate the flight and forced flight of Palestinians during the...